Deepak Nitrite Ltd
Incorporated in 1970, Deepak Nitrite Ltd manufactures Basic Intermediates, Fine
& Speciality Chemicals, Performance
Products, and Phenolics[1]
- Market Cap ₹ 20,848 Cr.
- Current Price ₹ 1,528
- High / Low ₹ 2,770 / 1,513
- Stock P/E 97.8
- Book Value ₹ 232
- Dividend Yield 0.49 %
- ROCE 10.1 %
- ROE 8.22 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 27.5%
Cons
- The company has delivered a poor sales growth of 2.53% over past five years.
- Company has a low return on equity of 12.9% over last 3 years.
- Earnings include an other income of Rs.134 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE 500 Nifty 500 BSE MidCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,270 | 1,327 | 1,336 | 1,233 | 1,455 | 1,792 | 2,230 | 1,809 | 2,511 | 3,034 | 2,724 | 2,526 | 2,434 | |
| 1,154 | 1,186 | 1,166 | 1,086 | 1,245 | 1,480 | 1,425 | 1,271 | 1,865 | 2,446 | 2,278 | 2,233 | 2,209 | |
| Operating Profit | 116 | 141 | 170 | 146 | 210 | 312 | 805 | 538 | 646 | 588 | 446 | 294 | 226 |
| OPM % | 9% | 11% | 13% | 12% | 14% | 17% | 36% | 30% | 26% | 19% | 16% | 12% | 9% |
| -0 | 1 | -0 | 83 | 6 | -2 | 1 | 13 | 71 | 101 | 203 | 149 | 134 | |
| Interest | 28 | 38 | 39 | 32 | 42 | 45 | 22 | 6 | 3 | 3 | 4 | 5 | 4 |
| Depreciation | 30 | 36 | 39 | 48 | 52 | 53 | 78 | 67 | 73 | 76 | 87 | 100 | 102 |
| Profit before tax | 58 | 68 | 91 | 149 | 122 | 212 | 706 | 479 | 642 | 610 | 558 | 338 | 254 |
| Tax % | 34% | 21% | 29% | 26% | 32% | 35% | 23% | 26% | 24% | 23% | 22% | 18% | |
| 38 | 53 | 65 | 111 | 83 | 138 | 544 | 355 | 486 | 469 | 433 | 276 | 213 | |
| EPS in Rs | 3.67 | 5.11 | 5.60 | 8.46 | 6.12 | 10.12 | 39.89 | 26.01 | 35.65 | 34.41 | 31.78 | 20.27 | 15.62 |
| Dividend Payout % | 27% | 20% | 21% | 14% | 21% | 20% | 11% | 21% | 20% | 22% | 24% | 37% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 3% |
| 3 Years: | 0% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | -15% |
| 3 Years: | -20% |
| TTM: | -37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 12% |
| 3 Years: | -11% |
| 1 Year: | -44% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 16% |
| 3 Years: | 13% |
| Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 297 | 326 | 453 | 706 | 917 | 1,031 | 1,464 | 1,817 | 2,229 | 2,598 | 2,927 | 3,099 | 3,138 |
| 508 | 545 | 495 | 574 | 462 | 328 | 219 | 8 | 24 | 11 | 32 | 50 | 35 | |
| 245 | 234 | 290 | 254 | 397 | 450 | 344 | 324 | 364 | 415 | 385 | 444 | 419 | |
| Total Liabilities | 1,061 | 1,126 | 1,261 | 1,559 | 1,802 | 1,835 | 2,054 | 2,177 | 2,644 | 3,050 | 3,372 | 3,620 | 3,620 |
| 461 | 549 | 593 | 568 | 569 | 589 | 720 | 776 | 674 | 728 | 835 | 898 | 934 | |
| CWIP | 71 | 38 | 14 | 41 | 36 | 29 | 90 | 69 | 83 | 77 | 126 | 170 | 151 |
| Investments | 3 | 17 | 133 | 358 | 455 | 563 | 563 | 689 | 909 | 1,057 | 945 | 1,372 | 1,408 |
| 526 | 522 | 520 | 593 | 742 | 654 | 682 | 644 | 978 | 1,188 | 1,466 | 1,179 | 1,127 | |
| Total Assets | 1,061 | 1,126 | 1,261 | 1,559 | 1,802 | 1,835 | 2,054 | 2,177 | 2,644 | 3,050 | 3,372 | 3,620 | 3,620 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14 | 105 | 191 | 93 | 214 | 277 | 515 | 442 | 228 | 310 | 418 | 254 | |
| -97 | -87 | -162 | -274 | -189 | -78 | -268 | -226 | -159 | -188 | -156 | -333 | |
| 108 | -22 | -28 | 178 | -25 | -198 | -248 | -215 | -64 | -113 | -106 | -88 | |
| Net Cash Flow | -3 | -4 | 1 | -2 | -0 | 2 | -1 | 1 | 4 | 9 | 157 | -167 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 84 | 86 | 81 | 93 | 93 | 70 | 60 | 71 | 80 | 72 | 82 | 89 |
| Inventory Days | 60 | 47 | 57 | 76 | 85 | 92 | 102 | 106 | 105 | 100 | 96 | 121 |
| Days Payable | 63 | 48 | 60 | 93 | 140 | 125 | 102 | 108 | 80 | 64 | 60 | 79 |
| Cash Conversion Cycle | 81 | 85 | 78 | 76 | 37 | 38 | 61 | 70 | 105 | 108 | 118 | 131 |
| Working Capital Days | 17 | -2 | -23 | -20 | -3 | 56 | 62 | 75 | 94 | 97 | 130 | 112 |
| ROCE % | 12% | 12% | 14% | 9% | 12% | 19% | 47% | 27% | 31% | 24% | 16% | 10% |
Documents
Announcements
-
Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Of November,2025
2d - SEBI special-window re-lodgement report for November 2025; zero transfer requests received/processed/approved/rejected.
-
Disclosure Under Regulation 30 Of SEBI LODR Regulations
4 Dec - Deepak Chem Tech began nitric acid plant operations on 4 Dec 2025; ~Rs.515 Crore capex at Nandesari, Gujarat.
-
Disclosure Under Regulation 30 Of SEBI LODR Regulations, 2015
28 Nov - DCTL allotted 3.5 million 9% OCRPS (Rs100) to DPL on Nov 28, 2025 for Rs35 crore.
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 20 Nov
-
Submission Of Audio Recording Of Earnings Con Call
14 Nov - Deepak Nitrite uploaded Q2 and H1 FY2026 earnings call audio on company website, November 14, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023Transcript PPT REC
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptPPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptPPT
-
Jan 2022TranscriptPPT
-
Oct 2021TranscriptPPT
-
Aug 2021TranscriptPPT
-
May 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Oct 2020TranscriptAI SummaryPPT
-
Aug 2020TranscriptAI SummaryPPT
-
May 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Oct 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Oct 2018TranscriptAI SummaryPPT
-
Aug 2018TranscriptAI SummaryPPT
-
May 2018TranscriptAI SummaryPPT
-
Jan 2018TranscriptAI SummaryPPT
-
Nov 2017TranscriptAI SummaryPPT
-
Aug 2017TranscriptAI SummaryPPT
-
Feb 2017TranscriptAI SummaryPPT
Business Segments
The company is one of the fastest growing chemical intermediates company in India with a portfolio of 32+ products and 56+ applications, divided into 2 segments: [1]